Search research articles
Contact Us
Filters
Showing results (181-190 of 241) with videos related to
Page
of 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2020
Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial
Talia Golan, Hedy L Kindler, Joon Oh Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2014
Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) study
Rosine Guimbaud, Christophe Louvet, Pauline Ries, et al.
Therapeutic Advances in Medical Oncology
|
June 7, 2024
Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study
Alix Riescher-Tuczkiewicz, Jules Grégory, Frederic Bert, et al.
Pancreas
|
September 11, 2015
Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma
Jean-Baptiste Bachet, Fabien Gay, Raphaël Maréchal, et al.
Therapeutic Advances in Medical Oncology
|
November 20, 2024
SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors
Pascal Hammel, Denis Smith, Pauline Afchain, et al.
Annals of Surgical Oncology
|
June 29, 2026
Is R1 Extended Liver Resection for Locally Advanced Intrahepatic Cholangiocarcinoma Justified? Nodal Status Not Margin Drives Prognosis
Edoardo Maria Muttillo, Daniel Cherqui, Marc-Anthony Chouillard, et al.
Annals of Surgical Oncology
|
July 6, 2026
ASO Visual Abstract: Is R1 Extended Liver Resection for Locally Advanced Intrahepatic Cholangiocarcinoma Justified? Nodal Status Not Margin Drives Prognosis
Edoardo Maria Muttillo, Daniel Cherqui, Marc-Anthony Chouillard, et al.
The Lancet. Gastroenterology & Hepatology
|
April 12, 2017
Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial
Jean-Baptiste Bachet, Pascal Hammel, Jérôme Desramé, et al.
Cancers
|
September 10, 2021
Targeting DNA Damage Repair Mechanisms in Pancreas Cancer
Lukas Perkhofer, Talia Golan, Pieter-Jan Cuyle, et al.
Clinical Genetics
|
August 22, 2019
Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort
Mathias Schwartz, Clement Korenbaum, Meriem Benfoda, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 241) with videos related to
Sort By:
Page
of 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2020
Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial
Talia Golan, Hedy L Kindler, Joon Oh Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2014
Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) study
Rosine Guimbaud, Christophe Louvet, Pauline Ries, et al.
Therapeutic Advances in Medical Oncology
|
June 7, 2024
Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study
Alix Riescher-Tuczkiewicz, Jules Grégory, Frederic Bert, et al.
Pancreas
|
September 11, 2015
Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma
Jean-Baptiste Bachet, Fabien Gay, Raphaël Maréchal, et al.
Therapeutic Advances in Medical Oncology
|
November 20, 2024
SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors
Pascal Hammel, Denis Smith, Pauline Afchain, et al.
Annals of Surgical Oncology
|
June 29, 2026
Is R1 Extended Liver Resection for Locally Advanced Intrahepatic Cholangiocarcinoma Justified? Nodal Status Not Margin Drives Prognosis
Edoardo Maria Muttillo, Daniel Cherqui, Marc-Anthony Chouillard, et al.
Annals of Surgical Oncology
|
July 6, 2026
ASO Visual Abstract: Is R1 Extended Liver Resection for Locally Advanced Intrahepatic Cholangiocarcinoma Justified? Nodal Status Not Margin Drives Prognosis
Edoardo Maria Muttillo, Daniel Cherqui, Marc-Anthony Chouillard, et al.
The Lancet. Gastroenterology & Hepatology
|
April 12, 2017
Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial
Jean-Baptiste Bachet, Pascal Hammel, Jérôme Desramé, et al.
Cancers
|
September 10, 2021
Targeting DNA Damage Repair Mechanisms in Pancreas Cancer
Lukas Perkhofer, Talia Golan, Pieter-Jan Cuyle, et al.
Clinical Genetics
|
August 22, 2019
Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort
Mathias Schwartz, Clement Korenbaum, Meriem Benfoda, et al.
Page
of 25